Abbott Laboratories buy Barclays PLC
Start price
22.04.24
/
50%
€100.82
Target price
22.04.25
€131.54
Performance (%)
-3.98%
Price
29.07.24
€96.81
Summary
This prediction is currently active. With a performance of -3.98%, the BUY prediction for Abbott Laboratories by Barclays_PLC is down slightly. This prediction currently runs until 22.04.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | 3.326% | 3.326% |
iShares Core DAX® | 1.280% | 1.027% |
iShares Nasdaq 100 | -2.457% | -4.650% |
iShares Nikkei 225® | -2.006% | -2.091% |
iShares S&P 500 | -0.662% | -1.246% |
Comments by Barclays_PLC for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Barclays PLC from $141.00 to $140.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Barclays_PLC for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€96.39
29.07.24
29.07.24
€132.17
29.07.25
29.07.25
0.44%
29.07.24
29.07.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€103.14
26.01.24
26.01.24
€129.82
26.01.25
26.01.25
-5.64%
29.07.24
29.07.24